Case Study Documents Link between Acute Ischemic Strokes and COVID-19

Pittsburgh-Based Neuroradiologist and Neurologists among the First to Publish Images of Blood Clotting and Decreased Blood Flow to the Brain in COVID-19 Patient

News provided by

Allegheny Health Network

May 15, 2020, 10:00 ET

PITTSBURGH, May 15, 2020 /PRNewswire/ -- A case study published Thursday in the American Journal of Neuroradiology by physicians from Allegheny General Hospital (AGH) in Pittsburgh provides some of the first angiographic images documenting the rapid progression of acute ischemic stroke in a patient with the novel coronavirus (COVID-19).

A, NCCT on the day of admission demonstrates subtle findings of acute ischemia in the right MCA (arrowheads) and bilateral ACA (arrows) territories, including hypoattenuation and loss of gray-white differentiation. B, Repeat NCCT on hospital day 2 demonstrates progression of acute infarcts in the right MCA and bilateral ACA territories, including worsening edema and mass effect.

The case study is the latest in a growing body of clinical observations and scientific evidence demonstrating a link between COVID-19 and the risk of stroke, particularly among individuals under the age of 50. Although definitive root causation is still to be determined, patients with severe cases of COVID-19 appear to be at a greater risk for blood clots. In addition, a recent study in The Lancet suggests the virus directly targets the endothelial cells that line blood vessels, which may also put the patient at risk for stroke.

An ischemic stroke can occur when vessels supplying blood to the brain are obstructed by clotting, leading to a potentially irreparable and fatal neurological injury.

"In some COVID-19 patients, we are observing that blood clots form at a notably fast pace," said Ashis Tayal, MD, neurologist and director of the Allegheny Health Network Stroke Center. "This manifestation of cerebrovascular ischemia can be particularly challenging for patients who are also experiencing severe respiratory distress and other medical issues associated with the virus."

The AHN case study, "Cerebrovascular Disease in COVID-19," documents a 64-year-old man who presented to the emergency department after waking up at home with symptoms of left-sided paralysis and shortness of breath. The patient had tested positive for COVID-19 16 days prior and was recovering well before his sudden onset of ischemic stroke. He passed away from complications of COVID-19 three days after admission to the hospital.

"The experience with COVID-19 to date world-wide provides a high degree of certainty that five to six percent of patients with severe cases may suffer a cerebrovascular injury. What's unique with our case is that the patient represented a subgroup where a stroke may occur in someone with atypical symptomatic onset. This patient was diagnosed with COVID-19 16 days prior to his stroke and was on his way to recovery from the virus before this suddenly occurred," said Michael Goldberg, MD, MPH, a neuroradiologist and Director of the Allegheny Health Network Division of Neuroradiology.

A recent case series of 214 COVID-19 patients from Wuhan, China published in JAMA Neurology (April 10, 2020, doi:10.1001/jamaneurol.2020.1127) reported that 36 percent of patients demonstrated neurologic manifestations, and acute cerebrovascular disease was reported in 6 percent of severely affected patients.

Similar observations have been made among COVID-19 patients in New York City. Physicians at Mt. Sinai hospital reported in the New England Journal of Medicine in May about a handful of patients under the age of 50 who had strokes within two weeks of being diagnosed with COVID-19 — a number that typically would be expected over the course of nearly seven weeks.

"As this pandemic progresses, we are learning more every day about how unpredictable this virus is in terms of its potential adverse impacts beyond the respiratory system," said Dr. Tayal. "Cerebrovascular injury is one such complication that can pose the most significant risk for a poor outcome among those who contract the disease, and which we will continue to focus on in our efforts to better treat it."

About the Allegheny Health Network:
Allegheny Health Network (AHN.org), a Highmark Health company, is an integrated healthcare delivery system serving the greater Western Pennsylvania region. The Network is composed of 12 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, an employed physician organization, home and community-based health services, a research institute, and a group purchasing organization. The Network provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, trauma care, cardiovascular disease, organ transplantation, cancer care, orthopedic surgery, neurology and neurosurgery, women's health, diabetes, autoimmune disease and more. AHN employs approximately 21,000 people, has more than 2,500 physicians on its medical staff and serves as a clinical campus for Drexel University College of Medicine, Temple University School of Medicine, and the Lake Erie College of Osteopathic Medicine.

SOURCE Allegheny Health Network